Table 1.
Demographic and clinical characteristics of the study participants.
| pSS (n = 30) | HCs (n = 20) | |
|---|---|---|
| Age, mean (SD) | 55.5 (8.80) | 50.7 (10.1) |
| Female, n (%) | 29 (96.7) | 19 (95.0) |
| Disease duration, years, median (interquartile range) | 2.03 (6.84) | - |
| ESSDAI, median (interquartile range) | 4.00 (5.00) | - |
| Involved system, n (%) | - | |
| Lymphadenopathy | 1 (3.33) | |
| Domain | 2 (6.67) | |
| Glandular domain | 5 (16.7) | |
| Articular domain | 2 (6.67) | |
| Cutaneous domain | 4 (13.33) | |
| Pulmonary domain | 1 (3.33) | |
| Renal domain | 0 (0) | |
| Muscular domain | 0 (0) | |
| Peripheral nervous system domain | 1 (3.33) | |
| Central nervous system domain | 10 (30.33) | |
| Hematological domain | 23 (76.67) | |
| Biological domain |
ESSDAI, EULAR Sjogren’s syndrome disease activity index.